Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of CS060380 in healthy and elevated LDL-C subjects; the listed condition is metabolic dy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• CS060380 (CS060380)

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: MASH | Phase 1 | Status: COMPLETED